| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC2407 | Gsk-756619 | Novel Plasmodium falciparum dihydroorotate dehydrogenase (PfDHODH) inhibitor |
|
| DCC2408 | Gsk791 | Negative control for GSK789 |
|
| DCC2409 | Gsk809 | Novel potent and selective BET pan-BD2 inhibitor |
|
| DCC2410 | Gsk8470 | Novel agonist of the orphan nuclear receptors steroidogenic factor-1 (SF-1, NR5A1) and liver receptor homologue-1 (LRH-1, NR5A2) |
|
| DCC2411 | Gsk866 | Selective glucocorticoid receptor agonist (SEGRA) |
|
| DCC2412 | Gsk8815 | Negative control for GSK8814 |
|
| DCC2413 | Gsk926 | Highly potent, selective, SAM-competitive, and cell-active EZH2 inhibitor |
|
| DCC2414 | Gsk932121 | Antimalarial |
|
| DCC2415 | Gsk943 | Negative control for GSK073 |
|
| DCC2416 | Gsk-943949a | Novel potent protein kinase C-related kinase 1 (PRK1) inhibitor with IC50 of 40±8.7 nM) |
|
| DCC2417 | Gsk945237 | Novel potent inhibitor of bacterial type IIA topoisomerases |
|
| DCC2418 | gsk966 | Selective inhibitor of iE-DAP-stimulated IL-8 release via the NOD1 signaling pathway |
|
| DCC2419 | Gsk966587 | Potent inhibitor of bacterial type IIA topoisomerases |
|
| DCC2420 | Gsk9772 | Novel potent transrepression-selective liver X receptor modulator with anti-inflammatory activity |
|
| DCC2421 | Gsk990 | Negative control as an inactive IDH1 inhibitor |
|
| DCC2422 | Gsm-10h | Next-generation NSAID-like γ-secretase modulator (GSM) with improved in vitro potency and brain penetration, effectively lowering Aβ42 production in cells and in amyloid precursor protein transgenic mice |
|
| DCC2423 | Gst-hg-121 | Novel hepatitis B surface antigen (HBsAg) inhibitor for the treatment of hepatitis B virus infection |
|
| DCC2424 | Gt-2331 | Novel potent histamine H3 receptor antagonist |
|
| DCC2425 | Gtpl10720 | Novel broad-spectrum inhibitor of coronavirus and enterovirus replication, targeting the main protease (Mpro or 3CLpro) |
|
| DCC2426 | Gtpl11148 | First-In-Class Antagonist against the Adrenomedullin-2 (AM2) Receptor |
|
| DCC2427 | Guanoxyfen Sulfate | Inhibitor of vasoconstrictor responses to sympathetic nerve stimulation, potentiating the actions of adrenaline and noradrenaline, increasing the blood glucose concentration and decreasing the appetite |
|
| DCC2428 | Guggulsterone-52 | Novel inhibitor of the activation of nuclear factor (NF)-κB signaling in bone marrow-derived dendritic cells, significantly inhibiting LPS-induced IL-12p40 and TNF-α gene expression, IκBα degradation, and NF-κB DNA binding activity in BMDCs, attenuating c |
|
| DCC2429 | Guineesine | Acyl-CoA, inhibiting cholesterol acyltransferase |
|
| DCC2430 | Gummadiol | Natural inhibitor of 3C-like protease (3CLpro), targeting SARS-CoV-2 3CLpro, SARS-CoV 3CLpro and MERS-CoV 3CLpro |
|
| DCC2431 | Gv2-20 | Potent inhibitor of cabonic anhydrase 2 (CA2) |
|
| DCC2432 | Gw 791343 Hydrochloride | Negative allosteric modulator of human P2X7 and a positive allosteric modulator of rat P2X7 |
|
| DCC2433 | gw0072 | Potent inhibitor of adipocyte differentiation and weak partial agonist of |
|
| DCC2434 | Gw012x | Novel Selective and Nonpeptidomimetic Proteasome Inhibitor As an Antimalarial, specifically inhibiting the proteasome activity in P. falciparum |
|
| DCC2435 | gw0791 | Novel agonist for retinoid X receptor |
|
| DCC2436 | Gw297361x | Inhibotor of active Vaccinia-Related Kinases (VRK) |
|
